KRISPY KREME ($DNUT) posted quarterly earnings results on Thursday, August 7th. The company reported earnings of -$0.15 per share, missing estimates of -$0.03 by $0.12. The company also reported revenue of $379,770,000, missing estimates of $385,677,983 by $-5,907,983.
You can see Quiver Quantitative's $DNUT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
KRISPY KREME Insider Trading Activity
KRISPY KREME insiders have traded $DNUT stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DNUT stock by insiders over the last 6 months:
- INDULGENCE B.V. JAB sold 694,445 shares for an estimated $3,000,002
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
KRISPY KREME Hedge Fund Activity
We have seen 108 institutional investors add shares of KRISPY KREME stock to their portfolio, and 63 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BAMCO INC /NY/ removed 9,423,758 shares (-72.1%) from their portfolio in Q1 2025, for an estimated $46,364,889
- COOPER CREEK PARTNERS MANAGEMENT LLC added 4,724,750 shares (+65.0%) to their portfolio in Q1 2025, for an estimated $23,245,770
- BARROW HANLEY MEWHINNEY & STRAUSS LLC added 3,742,257 shares (+350.9%) to their portfolio in Q1 2025, for an estimated $18,411,904
- CITADEL ADVISORS LLC removed 3,367,595 shares (-77.1%) from their portfolio in Q1 2025, for an estimated $16,568,567
- MILLENNIUM MANAGEMENT LLC added 1,732,732 shares (+480.4%) to their portfolio in Q1 2025, for an estimated $8,525,041
- FEDERATED HERMES, INC. added 1,681,133 shares (+inf%) to their portfolio in Q1 2025, for an estimated $8,271,174
- GOLDMAN SACHS GROUP INC removed 1,492,211 shares (-74.8%) from their portfolio in Q1 2025, for an estimated $7,341,678
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
KRISPY KREME Congressional Stock Trading
Members of Congress have traded $DNUT stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $DNUT stock by members of Congress over the last 6 months:
- REPRESENTATIVE TIM MOORE has traded it 2 times. They made 2 purchases worth up to $65,000 on 07/30, 07/29 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
KRISPY KREME Analyst Ratings
Wall Street analysts have issued reports on $DNUT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 07/18/2025
- Truist Securities issued a "Buy" rating on 04/24/2025
- Morgan Stanley issued a "Underweight" rating on 02/26/2025
- Piper Sandler issued a "Overweight" rating on 02/26/2025
To track analyst ratings and price targets for KRISPY KREME, check out Quiver Quantitative's $DNUT forecast page.
KRISPY KREME Price Targets
Multiple analysts have issued price targets for $DNUT recently. We have seen 5 analysts offer price targets for $DNUT in the last 6 months, with a median target of $6.0.
Here are some recent targets:
- Sara Senatore from B of A Securities set a target price of $6.0 on 07/18/2025
- John Glass from Morgan Stanley set a target price of $2.5 on 07/14/2025
- Jon Tower from Citigroup set a target price of $3.6 on 05/09/2025
- Bill Chappell from Truist Securities set a target price of $7.0 on 04/24/2025
- Brian Mullan from Piper Sandler set a target price of $12.0 on 02/26/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
